Aktie A217730 KANGSTEM BIOTECH CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Kangstem Biotech Co., Ltd.

Aktien

A217730

KR7217730001

A217730

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 28.05.2024 		% 5 Tage % 1. Jan.
2.530 KRW +1,61 % Intraday Chart für Kangstem Biotech Co., Ltd. -0,98 % +5,64 %
2023 Kangstem Biotech Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
An undisclosed buyer agreed to acquire a 24.27% stake in Croen Inc. from Kangstem Biotech Co., Ltd. for KRW 2.8 billion
Kangstem Biotech Co., Ltd.(KOSDAQ:A217730) dropped from S&P Global BMI Index
Kang Stem Biotech to Raise 35.1 Billion Won via Shares Issuance; Shares Plunge 30%
Kangstem Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Kang Stem Biotech Co., Ltd. announced that it has received KRW 47.99962221 billion in funding from a group of investors
Kang Stem Biotech Co., Ltd. announced that it expects to receive KRW 47.99962221 billion in funding from a group of investors
Kang Stem Biotech Co., Ltd. cancelled the acquisition of 60% stake in Croen Inc.
Kang Stem Biotech Co., Ltd. announced that it has received KRW 1.40 billion in funding
Kang Stem Biotech Co., Ltd. agreed to acquire a 60% stake in Croen Inc. for KRW 2.7 billion.
Kang Stem Biotech Co., Ltd. announced that it expects to receive KRW 1.40 billion in funding
Kang Stem Biotech Co., Ltd. announced that it has received KRW 30 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, LIG Investment & Securities Co., Ltd., Investment Arm, and other investors
Kang Stem Biotech Co., Ltd. announced that it expects to receive KRW 30 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, LIG Investment & Securities Co., Ltd., Investment Arm, and other investors
ORIG3N, Inc and Kangstem Biotech Announce Collaboration to Study Neural Stem Cells
Lutronic Corporation cancelled the sale of 4.11% stake in Kang Stem Biotech Co., Ltd.
Kang Stem Biotech Co., Ltd.(KOSDAQ:A217730) added to S&P Global BMI Index
Kang Stem Biotech Co., Ltd. has completed an IPO in the amount of KRW 12.00 billion.
Kang Stem Biotech Co., Ltd. has filed an IPO in the amount of KRW 20.00 billion.
Lutronic Corporation signed a contract to sell 4.11% stake in Kang Stem Biotech Co., Ltd. for KRW 2.4 billion.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A217730 Aktie
  4. Nachrichten Kangstem Biotech Co., Ltd.
  5. Andere Sprachen